PharmTech Polls Archive - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Polls Archive

Pharmaceutical Technology

Welcome to PharmTech Polls! Participate in our current poll and make your opinion count. And don’t forget to check out the poll archive to see past questions and responses.

Click here for the current poll on "biologics manufacturing;

To comment on this or any past poll, email us.

 

Poll Archive

Click here for the results of "powder properties"

Click here for the results of "sterile manufacturing"

Click here for the results of "social media"

Click here for the results of "USP monographs"

Click here for the results of "API manufacturing"

Click here for the results of "lyophilisation advances"

Click here for the results of "injection technologies"

Click here for the results of "oral drug delivery"

Click here for the results of "generic drug user fees"

Click here for the results of "solid dosage innovation"

Click here for the results of "small molecule API outsourcing"

Click here for the results of "USP monographs"

Click here for the results of "anticounterfeiting solutions"

Click here for the results of "quality by design and APIs"

Click here for the results of "outsourcing biologics"

Click here for the results of "FDA biosimilars strategy"

Click here for the results of "highly potent APIs"

Click here for the results of "biosimilars"

Click here for the results of "strategies for emerging markets"

Click here for the results of "atypical actives"

Click here for the results of "shared audits"

Click here for the results of "continuous processing"

Click here for the results of "Carbon footprint"

Click here for the results of "Immediate release drug delivery"

Click here for the results of "QbD and CMC"

Click here for the results of "Interphex 2011"

Click here for the results of "FDA transparency"

Click here for the results of "Tableting Equipment"

Click here for the results of "Outsourcing Levels"

Click here for the results of "FDA Recalls"

Click here for the results of "Granulation Techniques"

Click here for the results of "Pharma Forecast for 2011"

Click here for the results of "Needleless Devices"

Click here for the results of "Trade Show Attendance"

Click here for the results of "Regulation of Excipients"

Click here for the results of "Generic-Drug User Fees"

Click here for the results of "Cleanroom Challenges"

Click here for the results of "Small-Molecule Outsourcing"

Click here for the results of "Secondary packaging"

Click here for the results of "Single-use Technologies"

Click here for the results of "Pay-to-Delay"

Click here for the results of "Outsourcing Concerns"

Click here for the results of "Outsourcing"

Click here for the results of "Green Manufacturing Efforts"

Click here for the results of "Biosimilars: Threat or Opportunity?"

Click here for the results of: "Expanding FDA's Power"

Click here for the results of: "Anticounterfeiting Solutions"

Click here for the results of: "Novel Excipients "

Click here for the results of: "Tablet Manufacture"

Click here for the results of: "Equipment Purchasing "

Click here for the results of: "US Healthcare Reform "

Click here for the results of: "Recession"

Click here for the results of: "Ingredient Suppliers "

Click here for the results of:"FDA Spending"

Click here for the results of: "CMO Market "

Click here for the results of: "Lyophilization"

Click here for the results of:" Pharma's Economic Recovery"

Click here for the results of: "M&As in 2010"

Click here for the results off "2010 Innovation"

Click here for the results of: "Oral Drug Delivery"

Click here for the results of:" Drug Delivery Technologies"

Click here for the results of: “The Next Generation of Innovators”

Click here for the results of: “Aseptic Processing”

Click here for the results of: “FDA's 2nd Transparency Meeting”

Click here for the results of: “Small-Molecule Contract Manufacturing”

Click here for the results of: “Packaging Innovation”

Click here for the results of: “Implementing Green Chemistry”

Click here for the results of: “FDA's Enforcement Plan”

Click here for the results of: “Counterfeit Drug Regulation”

Click here for the results of: “Biologics Data Exclusivity”

Click here for the results of: “Stem-Cell Research”

Click here for the results of: “The Influenza Pandemic”

Click here for the results of: “FDA's Transparency Task Force”

Click here for the results of: “The Follow-on Biologics Pathway”

Click here for the results of: “Split FDA?”

Click here for the results of: “QbD for Excipients”

Click here for the results of: “Comparative-Effectiveness Research”

Click here for the results of: “Excipients Issues”

Click here for the results of: “Equipment Reliability”

Click here for the results of: “Outsourcing Decline?”

Click here for the results of: “Daschle Out”

Click here for the results of: “Outsourcing in 2009”

Click here for the results of: “Workforce Reductions”

Click here for the results of: “Daschle for HHS”

Click here for the results of “Pharma Forecast for 2009”

Click here for the results of: “The New FDA Commish”

Click here for the results of: “Harmonization”

Click here for the results of: “Pharma Videos”

Click here for the results of: “Sourcing Ingredients”

Click here for the results of: “The Next President”

Click here for the results of: “Clinical Trial Results”

Click here for the results of: “Off-Label Prescribing”

Click here for the results of: “REACH in the EU”

Click here for the results of: “FDA's Complete Response Letters”

Click here for the results of: “FDA's Black-Box Warnings”

Click here for the results of: “Outsourced or In-House?”

Click here for the results of: “Imported Ingredients.”

Click here for the results of: “Rising Costs.”

Click here for the results of: “Country-of-Origin Labeling.”

Click here for the results of: “Funding FDA Inspections.” View comments on this poll.

Click here for the results of: “California ePedigree Delay”

Click here for the results of: “Generation Gap?”

Click here for the results of: “Industry Conferences”

Click here for the results of: “Process Analytical Technology and Scale Up”

Click here for the results of: “Should Pharma Leave China?”

Click here for the results of: “Paying for Quality by Design Initiatives”

Click here for the results of: “Direct-to-Consumer Advertising”

Click here for the results of: “The Presidential Candidates”

Click here for the results of: “Pharma forecast for 2008”

Click here for the results of: “Weigh in on FDA’s foreign inspection process.”

Click here for the results of: “Weigh in on OTC children's medications.”

Click here for the results of: “The future of inhalation delivery.”

Click here for the results of: “How do you define ‘PAT’?”

Click here for the results of: “How do you define ‘design space’?”

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Looking forward 10 years from now, what do you think will be the most significant change to drug development and manufacturing?
Fuller adoption of quality by design principles
Greater adoption of continuous manufacturing
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
The rise of biologic-based drugs in commercial product portfolios and pipelines
Greater adoption of the preferred provider model in outsourcing
Fuller adoption of quality by design principles
22%
Greater adoption of continuous manufacturing
7%
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
35%
The rise of biologic-based drugs in commercial product portfolios and pipelines
30%
Greater adoption of the preferred provider model in outsourcing
7%
View Results
Jim MillerOutsourcing OutlookJim Miller Channeling Steve Jobs
Patricia Van ArnumIngredients InsiderPatricia Van ArnumSeeking Chemocatalytic and Biocatalytic Solutions
Nathan JessopIndustry InsiderNathan Jessop Taxing Times for French Pharma
Lynn D. TorbeckStatistical Solutions Lynn D. TorbeckRepresentative Sampling
Report on Recent and Upcoming Single-Use Meetings
ICH Q11 Reaches Harmonization, Implementation is Next
Digital Signatures Growing as a Result of Part 11
Single-Cell Genomics Advancing Molecular Biology
Putting FDA’s “Process Validation” Guidance into Action
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here